Inhibits EED H3K27me3 recognition by binding to the H3K27me3 binding pocket. Inhibits growth in DLBCL cell lines that have acquired resistance to EZH2 inhibitors. Also active in a xenograft murine model. Here, EZH2 is linked to diffuse large B-cell lymphoma.